Correlation of CD4 counts and CD4/CD8 ratio with HIV-infection associated oral manifestations

East African Medical Journal

Volumn 84, Issue 8, 2007, Pages 383-388

  Butt, F M A ^a   Vaghela, V P ^b   Chindia, M L ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b Department of Obstetrics and Gynaecology   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDIASIS; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CHEILITIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; KENYA; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MOUTH DISEASE; PATHOLOGY; PREVALENCE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD4; ANTIGENS, CD8; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; CHEILITIS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; KENYA; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MOUTH DISEASES; PREVALENCE; SARCOMA, KAPOSI; SEX FACTORS;

EID: 35248831795     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lalwani A.K. and Sooy CD. Otologic and neurologic manifestations of acquired immunodeficiency syndrome. Otolaryngol. Clin. North Amer. 1992; 25:1183-1197.
2. Graham N.M. The role of immunologic and viral markers in predicting clinical outcome in HIV infection. AIDS. 1996; 10 suppl: 21-25.
3. Patton L.L. Sensitivity, specificity and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immunesuppression and viral burden. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2000; 90:182-188.
4. Fahey J.L., Taylor K.M., Detels R., et al. The prognostic value of cellular and serologic markers in infection with immunodeficiency virus type 1. N. Engl. J. Med. 1990; 322: 166-172.
5. Melnick S.L. A guide for epidemiological studies of oral manifestations of HIV infection. World Health Organization, Geneva 1993.
6. Quinn T.C. Laboratory tests in the management of HIV infection. Bartlett J. (editorial). 1997; 20: 30.
7. Phillips A.N., Lee C.A., Elford J., et al. Serial CD4 lymphocyte counts and development of AIDS. Lancet. 1991; 337:389-392.
8. Maeve M.C., Greenspan J. and Challacombe S.J. Oral lesions in infection with human immunodeficiency virus. Bull. World Health Org. 2005; 83: 706-709.
9. Matee M.I., Scheuz F. and Moshy J. Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis. 2000; 6: 106-111.
10. Geneva: World Health Organization; May 2004. Accessed June 17, 2004 at http://www.who.int/whr.
11. Kramer I.R., Pindborg J.J., Bezroukkou., et al. Guide to epidemiology and diagnosis of oral mucosal diseases and conditions, World health organisation. Comm. Dent. Oral Epidemiol. 1980; 8:1-16.
12. Tukutuku K., Muyembe-Tamfum L., Kayembe K., et al. Oral manifestations of AIDS in a heterosexual population in a Zaire hospital. J. Oral Pathol. Med. 1990; 19: 232-234.
13. Jonsson N., Zimmerman M., Chidzonga M.M., et al. Oral manifestations in 100 Zimbabwean HIV/AIDS patients referred to a specialist center. Cent. Afr. J. Med. 1998; 44: 31-34.
14. Hodgson T.A. HIV- associated oral lesions: prevalence in Zambia. Oral Dis. 1997; 3: S46-S50.
15. Itula P.F.B., Mackenzie S.B.P., Lewis K., et al. Orofacial manifestations and seroprevalence of HIV infection in Namibian dental patients. Oral Dis. 1997; 3: S51-S53.
16. Arendorf T.M., Bredekamp B., Cloete C., et al. Intergroup comparision of oral lesions in HIV-positive South Africans. Oral Dis. 1997; 3: S54-S57.
17. Centres for disease control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 1992; 41: 1-19.
18. Margotta V., Campisi G., Mancuso S., et al. HIV infection: Oral lesion, CD4 cell count and viral, load in an Italian study population. J. Oral Pathol. Med.1999; 28:173-177.
19. Ramirez-Amador V., Esquivel-Pedrazal and Poncede-Leon S. The changing clinical spectrum of human immunodeficiecncy virus (HIV)-related lesions in 1000 consecutive patients. A twelve year study in a referral center in Mexico. Medicine. 2003; 82:39-50.
20. Ranganath K. and Hemalatha R. Oral lesions in HIV infection in developing countries. Adv. Dent. Res. 2006; 19: 63-68.
21. th World workshop on Health and Disease in AIDS., July 6-9, 2004, Phuket, Thailand. Advances in Dent. Res. 2005.
22. Brig. Sharma Y.K., Col. Sawhney M.P.S., Lt Col. Bhakuni D.S. and Maj. Gera V. Orocutaneous manifestations as markers of disease progression in HIV infection in Indian setting. Med. J. Armed Forces of India. 2004; 60: 239-243.
23. Schulten E.A., Ten kate R.W. and Van der Waal I. Oral manifestations of HIV infection in 75 Dutch patients. J. Oral Pathol. Med. 1989; 18: 42-46.
24. Campo J., Del Romero J., Castilla J., et al. Oral candidiasis as a clinical marker related to viral, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J. Oral Pathol. Med. 2002; 31: 5-10.
25. Laskaris G., Hadjivassiliou M. and Stratigos J. Oral signs and symptoms in 160 Greek HIV-infected patients. J. Oral Pathol. Med. 1992; 21:120-123.
26. Patton L.L., Phelan J. A., Ramos-Gomez F.J., et al. Prevalence and classification of HIV-infected oral lesion. Oral Dis. 2002; 8(suppl 2): 98-109.
27. Reichart P.A. Infections of the mouth mucosa (I). HIV infection - an epidemiological, clinical and therapeutic update. Mund Kiefer Gesichtscir. 1999; 3:236-241.
28. Ramirez-AmadorV.,Esquivel-PedrasaL., Lozada-NurF., et al. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomised clinical trial. Oral Oncol. 2002; 38:460-467.
29. Lin MC., Corbet E.F. and Lo E.C. Oral mucosal lesions in adult Chinese. J. Dent. Res. 2001; 80:1486-1490.
30. Levine A.M. and Tulpule A. Clinical aspects and management of AIDS-related Kaposi's sarcoma, Eur. J. Cancer. 2001; 37:1288-1295.